(Press-News.org) HOUSTON and SAN MATEO, Calif. ― The University of Texas MD Anderson Cancer Center and Panacea Venture today announced the launch of Manaolana Oncology Inc., a new company created to develop and advance antibody-based therapies against novel cancer antigens.
Manaolana Oncology seeks to build upon the innovative antibody production capabilities and intellectual property of MD Anderson to research and develop novel monoclonal antibodies (mAbs) and other antibody-based therapies for a variety of cancer types, with the goal of advancing promising therapies into clinical studies at MD Anderson.
The company will be headquartered in Thousand Oaks, Calif., and will be led by an executive team with more than 100 years of combined experience in product development and strategic partnering. Panacea will fund start-up expenses for Manaolana Oncology and will support the recruitment of additional experienced executives to shape the company.
“By developing therapies targeting new tumor antigens, Manaolana Oncology aims to address a critical need for patients with cancer. Manaolana is the Hawaiian word for hope, and it is our intent to offer patients renewed hope against this disease,” said Winson Tang, M.D., co-founder of Manaolana Oncology. “Manaolana Oncology brings together MD Anderson’s expert scientists and clinicians with Panacea’s experienced biotechnology team to create a focused organization working to develop a novel portfolio of monoclonal antibodies.”
Monoclonal antibody therapies have emerged as important treatment options for many types of cancer. They are designed to recognize and bind to specific targets, or antigens, on cancer cells in order to manipulate certain signaling pathways or recruit immune cells to the tumor.
The laboratory of Samir Hanash, M.D., Ph.D., professor of Clinical Cancer Prevention at MD Anderson, has conducted an extensive characterization of the cancer surfaceome, resulting in a comprehensive catalogue of proteins found specifically on the surface of cancer cells across tumor types.
“By combing through petabytes of proteomic data, our team has uncovered many cancer-restricted antigens that may offer prime targets for monoclonal antibody therapies,” Hanash said. “We look forward to collaborating with Manaolana Oncology to develop novel antibody-based therapeutics that offer patients impactful new treatment options.”
Kevin McBride, Ph.D., associate professor of Epigenetics and Molecular Carcinogenesis at MD Anderson, has pioneered a high-throughput platform to clone and produce mAbs from isolated B cells, enabling the development of highly specific antibodies against a particular cell surface target to create novel therapeutic mAbs.
“This is an important evolution because current approaches to creating high-quality monoclonal antibodies require lengthy and intensive production protocols, which can be costly and are not always successful,” McBride said. “We look forward to working with Manaolana Oncology to build on these techniques and rapidly bring forward innovative therapies for clinical evaluation.”
Manaolana Oncology intends to optimize the techniques developed at MD Anderson in order to improve the speed and efficiency in of producing antibodies against promising candidate antigens.
Read this press release in the MD Anderson Newsroom.
-30-
Disclosure
MD Anderson has an institutional conflict of interest (COI) with Panacea and Manaolana Oncology due to MD Anderson’s ownership interest in Manaolana and the future research to be conducted at MD Anderson. These relationships will be managed according to an MD Anderson Institutional COI Management and Monitoring Plan.
About Panacea Venture
Panacea Venture is a life sciences venture capital firm with global vision and presence across three continents. The firm was founded in 2017 and is currently managing four funds investing in early-stage companies through public investments. Panacea incubates early-stage companies with breakthrough technologies and discoveries that can potentially address unmet medical needs to enhance quality of life on a global scale. The investment team has more than 100 years of combined investing experience and, along with venture partners and advisors, provides broad coverage across emerging and established biotech, diagnostic and medtech sectors. In addition, Panacea’s highly experienced team has a strong track record navigating portfolio companies to success.
About MD Anderson
The University of Texas MD Anderson Cancer Center in Houston ranks as one of the world's most respected centers focused on cancer patient care, research, education and prevention. The institution’s sole mission is to end cancer for patients and their families around the world, and, in 1971, it became one of the nation’s first National Cancer Institute (NCI)-designated comprehensive cancer centers. MD Anderson is No. 1 for cancer in U.S. News & World Report’s “Best Hospitals” rankings and has been named one of the nation’s top two hospitals for cancer since the rankings began in 1990. MD Anderson receives a cancer center support grant from the NCI of the National Institutes of Health (P30 CA016672).
END
MD Anderson and Panacea launch Manaolana Oncology to develop antibody-based therapies for cancer
2023-09-06
ELSE PRESS RELEASES FROM THIS DATE:
Obesity-related cardiovascular disease deaths tripled between 1999 and 2020
2023-09-06
Research Highlights:
Obesity-related cardiovascular disease deaths tripled between 1999 and 2020 in the U.S.
Such deaths were higher among Black individuals (highest among Black women) compared with any other racial group, followed by American Indian/Alaska Native people.
Black adults who lived in urban communities experienced more obesity-related cardiovascular disease deaths than those living in rural areas, whereas the reverse was true for all other racial groups.
This news release has been updated to include ...
Switching from harmful to helpful fungi
2023-09-06
Mold and diseases caused by fungi can greatly impact the shelf life of fruit and vegetables. However, some fungi benefit their hosts by aiding plant survival. Colletotrichum tofieldiae (Ct) is a root mold which typically supports continued plant development even when the plant is starved of phosphorus, an important nutrient for photosynthesis and growth. Researchers studied a unique pathogenic strain of the fungi, called Ct3, which conversely inhibits plant growth. By comparing the beneficial and harmful strains Ct strains, they found that activation of a single fungal secondary metabolism gene cluster determined the negative impact of the fungus on the host ...
Does cyberbullying affect adolescents’ risk of developing eating disorders?
2023-09-06
In a study of US adolescents, both victims and perpetrators of cyberbullying were more likely than other youth to experience eating disorder symptoms. The findings are published in the International Journal of Eating Disorders.
In the study of 10,258 adolescents aged 10–14 years, participants answered questions about whether they had experienced cyberbullying victimization and perpetration, as well as whether they had experienced eating disorder symptoms.
Cyberbullying victimization was associated with worrying about weight ...
Are children’s growing pains tied to migraines?
2023-09-06
New research published in Headache reveals that, in children and adolescents, pain in the lower limbs—what are often called “growing pains” by clinicians and are commonly attributed to rapid growth—may indicate the presence or risk of migraines.
The study included 100 children and adolescents born to mothers with migraines seen at a headache clinic, with half of the youth experiencing growing pains.
“In families of children with growing pains, there is an increased prevalence of other pain syndromes, especially migraine ...
Are antipsychotic drugs being appropriately prescribed to homebound patients with dementia?
2023-09-06
New research published in the Journal of the American Geriatrics Society indicates that antipsychotics are likely overprescribed and used inappropriately among patients with Alzheimer’s disease and related dementias (ADRD) receiving home health care, and such use is linked to worse patient outcomes.
Antipsychotic drugs are not approved for the treatment of dementia—they are mostly used off-label to manage the symptoms that many people with ADRD experience, such as agitation, aggression, and psychosis that are called “behavioral and psychological symptoms of dementia.” In addition, ...
New method enables efficient isolation of raccoon-borne food poisoning pathogen
2023-09-06
Osaka, Japan – As cute as raccoons may look, their behaviors are troublesome, and so are their droppings. Known to contain Escherichia albertii—a harmful enteropathogen—raccoon feces challenge zoonotic researchers who grapple to isolate this bacterium for further study. Fortunately, Osaka Metropolitan University scientists have come up with a novel culture medium for efficient isolation of E. albertii, making progress toward alleviating this particular raccoon-conveyed threat.
Due ...
Easier and faster materials microstructure analysis through human-AI collaboration!
2023-09-06
The research team led by Dr. Se-Jong Kim and Dr. Juwon Na of the Materials Data Management Center in the Materials Digital Platform Division together with the research team led by Professor Seungchul Lee of POSTECH has developed a technology that can automatically identify and quantify materials microstructure from microscopic images through human-in-the-loop machine learning. KIMS is a government-funded research institute under the Ministry of Science and ICT.
Microscopic imaging systems visualize material structure information at multiple ...
Psychedelic rock gecko among dozens of species in need of further conservation protection in Vietnam
2023-09-06
Further conservation measures are required to protect Vietnamese reptiles, such as the psychedelic rock gecko (Cnemaspis psychedelica), from habitat loss and overharvesting, concludes a new report, published in the open-access scientific journal Nature Conservation.
Having identified areas of high reptile diversity and large numbers of endangered species, the study provides a list of the 50 most threatened species as a guide for further research and conservation action in Vietnam.
The study, based on the bachelor thesis of Lilli Stenger (University of Cologne, Germany), recommends IUCN CPSG’s ...
MCG Anesthesiology Externship Program helps grow profession
2023-09-06
A unique program that sees students at the Medical College of Georgia working as anesthesia technologists throughout their four years of medical school can influence more of them to pursue the specialty as a career, investigators report.
The MCG Department of Anesthesiology and Perioperative Medicine’s nearly 100-year-old Externship Program is one of only five or six in the country and allows interested medical students to work nights, weekends and holidays, as a critical part of the anesthesia and operating room teams. Anesthesia techs are typically responsible for sterilizing, cleaning, assembling, calibrating, testing and troubleshooting various pieces of machinery in the operating ...
Non-binary and transgender Californians suffered alarming levels of physical and sexual violence in the past year
2023-09-06
WASHINGTON (September 6, 2023) – An annual survey of physical and sexual violence suffered by Californians documents for the first time the higher incidence of violence among non-binary and transgender people. One in 20 California adults has experienced physical violence (5%) in the past year, a decrease from 8% in 2022, according to The California Violence Experiences Study (CalVEX); but the reported rates for non-binary and transgender individuals were notably higher, 14% and 27%, respectively.
“The new data we have in this year’s report show that rates of violence have declined since levels seen during the pandemic, but these experiences remain too ...